柘中股份(002346.SZ)控股股东4000万股质押延期购回
格隆汇3月11日丨柘中股份(002346.SZ)公布,公司近日接到公司控股股东上海康峰投资管理有限公司关于其持有的公司合计4000万股股权质押延期购回的通知,延期后的质押到期日为2021年3月8日。
公司控股股东未来半年内到期的股份质押累计数量为1.38亿股,占其持有公司股份的50.02%,占公司总股本的31.27%,融资余额为5亿元;未来一年内(含半年内到期)合计到期的质押股份累计数量为1.78亿股,占其持有公司股份的64.51%,占公司总股本的40.33%,对应融资余额为6.5亿元。公司控股股东还款资金来源主要来自于其经营所得、自筹资金,具备相应的资金偿还能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.